Microcolony formation:: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung

被引:271
作者
Sriramulu, DD
Lünsdorf, H
Lam, JS
Römling, U
机构
[1] Karolinska Inst, Microbiol & Tumor Biol Ctr MTC, S-17177 Stockholm, Sweden
[2] Gesell Biotechnol Forsch mbH, Dept Cell Biol & Immunol, D-38124 Braunschweig, Germany
[3] Gesell Biotechnol Forsch mbH, Dept Microbiol, D-38124 Braunschweig, Germany
[4] Univ Guelph, Dept Microbiol, Guelph, ON N1G 2W1, Canada
关键词
D O I
10.1099/jmm.0.45969-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pseudomonas aeruginosa colonizing the lung of cystic fibrosis patients is responsible for a decline in health and poor prognosis for these patients. Once established, growth of P. aeruginosa in microcolonies makes it very difficult to eradicate the organisms by antimicrobial treatment. An artificial sputum medium was developed to mimic growth of P. aeruginosa in the cystic fibrosis lung habitat and it was found that the organisms grew in tight microcolonies attached to sputum components. Several genes, such as algD, oprF and lasR but not fliC, were required for tight microcolony formation. Among the sputum components, amino acids, lecithin, DNA, salt and low iron were required for tight microcolony formation. Amino acids were also shown to be responsible for various other cystic-fibrosis-specific phenotypes of P. aeruginosa, such as diversification of colony morphology, alterations in LPS structure and hyperexpression of OprF. Since the amino acid content of sputum is elevated in severe lung disease, it is suggested that the tight microcolony biofilm is maintained in these conditions and that they contribute to the vicious cycle of disease severity and failure to eradicate the organism. Thus, growth of P. aeruginosa in artificial sputum medium is an appropriate model of chronic lung colonization and may be useful for evaluating therapeutic procedures and studying antibiotic-resistance mechanisms.
引用
收藏
页码:667 / 676
页数:10
相关论文
共 50 条
[1]   The Pseudomonas aeruginosa flagellar cap protein, FliD, is responsible for mucin adhesion [J].
Arora, SK ;
Ritchings, BW ;
Almira, EC ;
Lory, S ;
Ramphal, R .
INFECTION AND IMMUNITY, 1998, 66 (03) :1000-1007
[2]   IMMUNOHISTOPATHOLOGIC LOCALIZATION OF PSEUDOMONAS-AERUGINOSA IN LUNGS FROM PATIENTS WITH CYSTIC-FIBROSIS - IMPLICATIONS FOR THE PATHOGENESIS OF PROGRESSIVE LUNG DETERIORATION [J].
BALTIMORE, RS ;
CHRISTIE, CDC ;
SMITH, GJW .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 140 (06) :1650-1661
[3]   The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa [J].
Barth, AL ;
Pitt, TL .
JOURNAL OF MEDICAL MICROBIOLOGY, 1996, 45 (02) :110-119
[4]   Global impact of mature biofilm lifestyle on Escherichia coli K-12 gene expression [J].
Beloin, C ;
Valle, J ;
Latour-Lambert, P ;
Faure, P ;
Kzreminski, M ;
Balestrino, D ;
Haagensen, JAJ ;
Molin, S ;
Prensier, G ;
Arbeille, B ;
Ghigo, JM .
MOLECULAR MICROBIOLOGY, 2004, 51 (03) :659-674
[5]   Interactions between biofilms and the environment [J].
Beveridge, TJ ;
Makin, SA ;
Kadurugamuwa, JL ;
Li, ZS .
FEMS MICROBIOLOGY REVIEWS, 1997, 20 (3-4) :291-303
[6]   Differential binding to and biofilm formation on, HEp-2 cells by Salmonella enterica Serovar Typhimurium is dependent upon allelic variation in the fimH gene of the fim gene cluster [J].
Boddicker, JD ;
Ledeboer, NA ;
Jagnow, J ;
Jones, BD ;
Clegg, S .
MOLECULAR MICROBIOLOGY, 2002, 45 (05) :1255-1265
[7]  
Christensen BB, 1999, METHOD ENZYMOL, V310, P20
[8]   MICROBIAL BIOFILMS [J].
COSTERTON, JW ;
LEWANDOWSKI, Z ;
CALDWELL, DE ;
KORBER, DR ;
LAPPINSCOTT, HM .
ANNUAL REVIEW OF MICROBIOLOGY, 1995, 49 :711-745
[9]   Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1 [J].
Davey, ME ;
Caiazza, NC ;
O'Toole, GA .
JOURNAL OF BACTERIOLOGY, 2003, 185 (03) :1027-1036
[10]   MONOCLONAL-ANTIBODIES THAT DISTINGUISH INNER-CORE, OUTER-CORE, AND LIPID-A REGIONS OF PSEUDOMONAS-AERUGINOSA LIPOPOLYSACCHARIDE [J].
DEKIEVIT, TR ;
LAM, JS .
JOURNAL OF BACTERIOLOGY, 1994, 176 (23) :7129-7139